Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nuheara.
RELATED STOCKHEAD STORIES
Tech
Tech: The only ASX small cap in food delivery has gone from processing thousands to millions of orders
News
The picks and flicks of today’s ASX small cap quarterlies & financial outlooks
News
Short & Caught: The small caps investors are shorting right now
Health & Biotech
Health: Human cell proteins + cannabis = fountain of youth?
Health & Biotech
Health: Immuron takes a dive after drug fails in alcoholic hepatitis trial
Health & Biotech
Health: PainChek wants to know if its app can detect pain in babies
Health & Biotech
Health: Hear that? Nuheara is in play after someone tried to take it over
News
It’s not just Labor’s franking credit threat that’s already sending investors to America
Health & Biotech
Health: G Medical is close to listing on the NASDAQ and Hong Kong exchanges
News
Rise and Shine: What you need to know before the ASX opens
Tech
Nuheara spruiks strong sales but auditors are concerned about its future
Director trades: All the action is under the radar
Tech
Nuheara just revealed earbuds at CES that let you hear TV louder than anyone else in the room
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
News
Lunchtime ASX small cap wrap: who’s counting their winnings today
Health & Biotech
Here’s one critical thing to keep in mind when investing in MedTech stocks
Health & Biotech
